TCTR20220217008已完成4 期
Efficacy and safety of combination treatment of fractional carbon dioxide laser and acellular dermal matrix in the treatment of acne scar
Department of Dermatology, Faculty of Medicine Siriraj Hospital0 个研究点目标入组 28 人开始时间: 2022年2月17日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 28
研究概览
简要总结
At 1-, 3- and 6-months follow-up, both intervention (I) and control (C) sides were improved in terms of scar volume, pore volume and roughness with statistical significance. Acne scar volumes were reduced by 20.3% (I) versus 17.0% (C), and 22.6% (I) versus 20.1% (C) at 3- and 6-months follow-up respectively. No serious complication were observed in either group.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- All
入选标准
- •1.Moderate acne scar grading from global acne scar grading system both side of the dace for 3 months
- •2.Fitzpatrick skin type 3-5
排除标准
- •1.photosensitive dermatoses, Skin malignancy, keloid, immunocomporomised host, dermatitis or infeaction at treatment area
- •2.regular smoking
- •3.Pregnancy and lactating woman first 3 months
- •4.Cannot come back for follow up
- •5.AHA, retinoic acid or topical agents for acne scar within 6 months
- •6.Laser, RF within 3 months
- •7.Systemic steroid, immunosuppressive agents within 6 months
- •8. Oral isotretinoin within 12 months
- •9.Cannot sign her/his name on inform consent sheet
- •10.allergic to acellular dermal matrix / silicone (Megaheal)
研究者
相似试验
已完成
3 期
A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPDCOPDNCT00308191Dey128
已完成
3 期
A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil AloneEssential HypertensionNCT01456169Takeda507
已完成
2 期
A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisColitis, UlcerativeNCT03662542Janssen Research & Development, LLC214
已完成
3 期
Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%)Diabetes Mellitus, Type 2NCT00728351Novartis Pharmaceuticals317
已完成
3 期
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionGlaucoma, Open-AngleOcular HypertensionNCT01241240Allergan192